Thank you for commenting Dr. Brown. It looks like Bard has already developed a new product, Modified Onflex, and introduced it to market, somehow. The 510k bypass process again. Overall, each patient with a problem is just an involuntary subject in the device makers’ experiments. It’s incredible that this is now normal. Validating new products is not even necessary anymore. All it takes is an idea and it can be implanted in patients as soon as it’s produced and delivered to a surgeon. It’s hard to read these marketing pamphlets without feeling sick to see how uncontrolled the market is. Complete abdication of responsibility from the FDA, and the community of surgeons that use mesh. Surgeons should be refusing to use these experimental products.
https://www.crbard.com/CRBard/media/ProductAssets/DavolInc/PF10155/en-US/ciyiueckavqqyjsl4ryw6vg37isjda2v.pdf
Here is the experimental justification for the new absorbable ring, copied below. Preclinical data on lab pigs. Results may not correlate to humans. But it’s for sale, ready for implantation. Amazing. Any surgeon who reads the fine print is guilty of malpractice I think, if they use this product without informing the patient that it is unproven in humans, even in the short term, let alone long term. Or they can plead ignorance and blame the device maker.
“These images are from a porcine study using Ventrio™ Hernia Patch which contains the same SorbaFlex™ memory technology.*
“* Preclinical data on file at C. R. Bard, Inc. Results may not correlate to performance in humans.”